Mark R Waddle
Overview
Explore the profile of Mark R Waddle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
359
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Deufel C, Brost E, Dupere J, Wilson J, Waddle M, Stish B
Brachytherapy
. 2025 Feb;
PMID: 39966072
Purpose: To develop and deploy an electromagnetic (EM) tracking-based platform for pretreatment, patient-specific quality assurance of brachytherapy applicator digitization, with the goals of intercepting human errors and quantifying treatment planning...
2.
Mutter R, Golafshar M, Buras M, Comstock B, Jacobson M, DeWees T, et al.
Int J Radiat Oncol Biol Phys
. 2024 Sep;
121(2):352-364.
PMID: 39299551
Purpose: The optimal approach for partial breast irradiation (PBI) is unknown. We investigated a novel de-intensified 3-fraction PBI regimen for photons, protons, and brachytherapy. Methods And Materials: A multicenter nonrandomized...
3.
Dosimetric Features of Ultra-Hypofractionated Intensity Modulated Proton Therapy for Prostate Cancer
Gao R, Ma J, Pisansky T, Kruse J, Stish B, Kowalchuk R, et al.
Int J Part Ther
. 2024 Jun;
12:100015.
PMID: 38827121
Purpose: To report clinical and dosimetric characteristics of 5-fraction stereotactic ablative radiotherapy (SABR) using intensity modulated proton therapy (IMPT) for localized prostate cancer. Materials And Methods: All patients receiving IMPT...
4.
Sutton E, Kamdem Talom B, Ebner D, Weiskittel T, Breen W, Kowalchuk R, et al.
Mayo Clin Proc Innov Qual Outcomes
. 2024 Apr;
8(3):225-231.
PMID: 38681179
Objective: To evaluate the completeness and reliability of recurrence data from an institutional cancer registry for patients with head and neck cancer. Patients And Methods: Recurrence information was collected by...
5.
Sharifzadeh Y, Breen W, Harmsen W, Amundson A, Garda A, Routman D, et al.
JCO Clin Cancer Inform
. 2024 Apr;
8:e2300239.
PMID: 38630957
Purpose: The COVID-19 pandemic led to rapid expansion of telemedicine. The implications of telemedicine have not been rigorously studied in radiation oncology, a procedural specialty. This study aimed to evaluate...
6.
Breen W, Geno C, Waddle M, Qian J, Harmsen W, Burns T, et al.
Neurooncol Adv
. 2024 Mar;
6(1):vdae034.
PMID: 38550393
Background: This study aimed to determine whether proton craniospinal irradiation (CSI) decreased the dose to normal tissue and resulted in less toxicity than photon CSI for adult patients. Methods: This...
7.
Kowalchuk R, Mullikin T, Spears G, Johnson-Tesch B, Rose P, Siontis B, et al.
Radiother Oncol
. 2024 Mar;
195:110260.
PMID: 38548114
Objectives: Metastasis-directed stereotactic body radiation therapy (SBRT) has demonstrated robust clinical benefits in carefully selected patients, improving local control and even overall survival (OS). We assess a large database to...
8.
Chauhan K, Ebner D, Tzou K, Ryan K, May J, Kaleem T, et al.
Front Oncol
. 2023 Aug;
13:1200270.
PMID: 37588094
Prostate cancer patients undergoing external beam radiation therapy (EBRT) benefit from a full bladder to decrease bowel and bladder toxicity. Ultrasound may offer a proxy metric for evaluation, sparing CBCT...
9.
Jeans E, Ebner D, Takiyama H, Qualls K, Cunningham D, Waddle M, et al.
Cancers (Basel)
. 2023 Jun;
15(11).
PMID: 37297019
No standard treatment paradigm exists for previously irradiated locally recurrent rectal cancer (PILRRC). Carbon-ion radiotherapy (CIRT) may improve oncologic outcomes and reduce toxicity compared with combined modality therapy (CMT). Eighty-five...
10.
Gao R, Mullikin T, Aziz K, Afzal A, Smith N, Routman D, et al.
Int J Radiat Oncol Biol Phys
. 2023 May;
117(4):846-856.
PMID: 37244627
Purpose: To report oncologic, physician-assessed, and patient-reported outcomes (PROs) for a group of women homogeneously treated with modern, skin-sparing multifield optimized pencil-beam scanning proton (intensity modulated proton therapy [IMPT]) postmastectomy...